Skip to main content

Table 1 Patient characteristics at baseline

From: The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis

Parameter

Value

n

10

Sex (male : female)

7:3

Age (years old)

62.9±4.3

Duration of diabetes (years)

25.4 ± 2.3

Duration of HD (years)

4.1±1.1

BMI (kg/m2)

23.0±1.5

Dose of insulin (U/day)

11.6±1.9

Glycated albumin (%) *

24.1 ± 1.5

S-CPR (ng/ml)

6.7 ± 1.3

spKTV

1.44 ± 0.09

Cre (mg/dl)

9.72±0.91

PTH (pg/ml)

88.0 ± 31.4

AST (U/l)

9.3 ± 1.1

ALT (U/l)

9.7 ± 1.3

gGTP (U/l)

16.9 ± 2.2

Total choresterol (mg/dl)

162.1 ± 8.1

Triglyceride (mg/dl)

120.1 ± 20.6

Blood glucose (mg/dl)

162.1 ± 8.1

Complications

 

Macroangiopathy (− / +)

(6/4)

Neuropathy (− / +)

(0/10)

Retinopathy (− / +)

(0/10)

  1. Values are means ± SEM or n. *n=9.